NCT01786915View on ClinicalTrials.gov

Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Bendavia 10mg

DRUG

Bendavia 50mg

DRUG

Placebo

Trial Locations (1)

33014

Clinical Pharmacology of Miami Inc, Miami

All Listed Sponsors
lead

Stealth BioTherapeutics Inc.

INDUSTRY

NCT01786915 - Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days | Biotech Hunter | Biotech Hunter